Port site and distant metastases of gallbladder cancer after laparoscopic cholecystectomy diagnosed by positronemission tomography

World Journal of Gastroenterology

Volumn 14, Issue 41, 2008, Pages 6428-6431

  Hu, Jian Bin ^a   Sun, Xiao Nun ^a   Xu, Jing ^a   He, Chao ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Fluorodeoxyglucose; Gallbladder cancer; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GEMCITABINE; OXALIPLATIN; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISTANT METASTASIS; FEMALE; GALLBLADDER BIOPSY; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; PORT SITE METASTASIS; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; SQUAMOUS CELL CARCINOMA; ADENOSQUAMOUS CARCINOMA; CANCER STAGING; GALLBLADDER TUMOR; INCIDENTAL FINDING; LIVER TUMOR; METASTASIS; PATHOLOGY; SCINTISCANNING; TUMOR SEEDING;

AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLECYSTITIS; CHOLELITHIASIS; FEMALE; FLUORODEOXYGLUCOSE F18; GALLBLADDER NEOPLASMS; HUMANS; INCIDENTAL FINDINGS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM SEEDING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 63449126095     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6428     Document Type: Article

References (14)

1. Akyurek N, Irkorucu O, Salman B, Erdem O, Sare M, Tatlicioglu E. Unexpected gallbladder cancer during laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg 2004; 11: 357-361
2. Lundberg O. Port site metastases after laparoscopic cholecystectomy. Eur J Surg Suppl 2000; 27-30
3. Lomis KD, Vitola JV, Delbeke D, Snodgrass SL, Chapman WC, Wright JK, Pinson CW. Recurrent gallbladder carcinoma at laparoscopy port sites diagnosed by positron emission tomography: implications for primary and radical second operations. Am Surg 1997; 63: 341-345
4. Rodriguez-Fernandez A, Gomez-Rio M, Llamas-Elvira JM, Ortega-Lozano S, Ferron-Orihuela JA, Ramia-Angel JM, Mansilla-Rosello A, Martinez-del-Valle MD, Ramos-Font C. Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis. Am J Surg 2004; 188: 171-175
5. Herder GJ, Kramer H, Hoekstra OS, Smit EF, Pruim J, van Tinteren H, Comans EF, Verboom P, Uyl-de Groot CA, Welling A, Paul MA, Boers M, Postmus PE, Teule GJ, Groen HJ. Traditional versus up-front [18F] fluorodeoxyglucosepositron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol 2006; 24: 1800-1806
6. Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 2005; 104: 2658-2670
7. Sperti C, Pasquali C, Fiore V, Bissoli S, Chierichetti F, Liessi G, Pedrazzoli S. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms. Am J Surg 2006; 191: 743-748
8. Wakabayashi H, Akamoto S, Yachida S, Okano K, Izuishi K, Nishiyama Y, Maeta H. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture. Eur J Surg Oncol 2005; 31: 1175-1179
9. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004; 8: 90-97
10. Koh T, Taniguchi H, Yamaguchi A, Kunishima S, Yamagishi H. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET). J Surg Oncol 2003; 84: 74-81
11. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, Einhorn LH, Suh WW, Samson D, Delbeke D, Gorman M, Shields AF. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008; 49: 480-508
12. Nishiyama Y, Yamamoto Y, Fukunaga K, Kimura N, Miki A, Sasakawa Y, Wakabayashi H, Satoh K, Ohkawa M. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med 2006; 47: 633-638
13. Rodriguez-Fernandez A, Gomez-Rio M, Medina-Benitez A, Moral JV, Ramos-Font C, Ramia-Angel JM, Llamas-Elvira JM, Ferron-Orihuela JA, Lardelli-Claret P. Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol 2006; 93: 650-664
14. Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Acta Gastroenterol Belg 2007; 70: 331-338